Physician profile

Eric Weiss

Orange Park, FL

NPI 1700961018

$4,038.72

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,790.60
Consulting Fee$1,300.00
Food and Beverage$291.78

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biotissue Holdings INC. $3,649.73 2022-2024
Mentor Worldwide LLC $253.45 2019-2023 Mentor Memorygel Resterilizable Gel Sizer
Apyx Medical Corporation $40.69 2019-2020
Depuy Synthes Sales INC. $37.66 2023-2024 Quickanchor Ethibond
Galderma Laboratories, L.P. $26.01 2019-2020
Axogen $19.19 2024 Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector
Allergan, INC. $11.99 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric Weiss

$4,038.72

in general payments reported 2019-2025

Years
2019-2024
Top company
Biotissue Holdings INC.

https://glasscript.com/doctor/304033/eric-weiss

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.